The Kidney Cancer Association is a voluntary health organization dedicated to the eradication of death and suffering from renal cancers. www.KidneyCancer.org

What novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond
23:55
What novel therapies are on the horizon for metastatic renal cell carcinoma? 2019 and beyond
Why does immunotherapy not work for everyone with kidney cancer?
31:22
Why does immunotherapy not work for everyone with kidney cancer?
Novel combinational therapies:Is the increased toxicity worth the possibility of increased benefit?
23:25
Novel combinational therapies:Is the increased toxicity worth the possibility of increased benefit?
Systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma
24:53
Systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma
Best agents for 2nd line and treatment of metastatic clear cell renal cell carcinoma
28:50
Best agents for 2nd line and treatment of metastatic clear cell renal cell carcinoma
What is the best front line treatment for metastatic clear cell RCC in 2018?
27:47
What is the best front line treatment for metastatic clear cell RCC in 2018?
NEOADJUVANT THERAPY PRIOR TO SURGERY
11:55
NEOADJUVANT THERAPY PRIOR TO SURGERY
The Role of Cytoreductive Nephrectomy in the Treatment of Metastatic Renal Cell Carcinoma
20:51
The Role of Cytoreductive Nephrectomy in the Treatment of Metastatic Renal Cell Carcinoma
Why should I participate in a clinical trial? What’s in it for me?
28:09
Why should I participate in a clinical trial? What’s in it for me?
What are my options if my cancer comes back in my kidney?
26:55
What are my options if my cancer comes back in my kidney?
The Role of Metastasectomy in the Treatment of Metastatic Renal Cell Carcinoma
34:21
The Role of Metastasectomy in the Treatment of Metastatic Renal Cell Carcinoma
Adjuvant Therapy for Locally Advanced Renal Cell Carcinoma: Status in 2018
31:49
Adjuvant Therapy for Locally Advanced Renal Cell Carcinoma: Status in 2018
Management and Outcomes in the treatment of Locally Advanced Renal Tumors
27:08
Management and Outcomes in the treatment of Locally Advanced Renal Tumors
Treatment of the Incidental Renal Mass: What are my options and which one is best?
26:03
Treatment of the Incidental Renal Mass: What are my options and which one is best?
Recent clinical trial advances in RCC - Matt Milowsky, M.D.
20:05
Recent clinical trial advances in RCC - Matt Milowsky, M.D.
Integrating early palliative care in RCC management Jean Sellers, RN, MSN
20:53
Integrating early palliative care in RCC management Jean Sellers, RN, MSN
Managing the side effects of RCC treatment Sarah Yenser Wood, NP, RN, MSN, ANP, AOCNP
38:04
Managing the side effects of RCC treatment Sarah Yenser Wood, NP, RN, MSN, ANP, AOCNP
Panel for Questions and Conclusions
15:52
Panel for Questions and Conclusions
Welcome and Introduction to the Kidney Cancer Association Tracy Rose, M.D., MPH
30:11
Welcome and Introduction to the Kidney Cancer Association Tracy Rose, M.D., MPH
Advances in the Surgical Treatment of RCC Steve Riggs, M.D., FACS
33:06
Advances in the Surgical Treatment of RCC Steve Riggs, M.D., FACS
Sequencing therapies for metastatic RCC Rhonda Bitting, M.D.
24:13
Sequencing therapies for metastatic RCC Rhonda Bitting, M.D.
Genetics of RCC: Is my family at risk? Mary Dunn, RN, MSN, OCN, NP-C
21:04
Genetics of RCC: Is my family at risk? Mary Dunn, RN, MSN, OCN, NP-C
Adjuvant treatment of RCC Dan George, M.D.
36:23
Adjuvant treatment of RCC Dan George, M.D.
Use of Immunotherapy in RCC Asim Amin, M.D., PhD.
36:27
Use of Immunotherapy in RCC Asim Amin, M.D., PhD.
Kidney Cancer Association Introduction - Sandy Srinivas, M.D.
27:38
Kidney Cancer Association Introduction - Sandy Srinivas, M.D.
Interns in Research - Thomas Metzner, MS
27:38
Interns in Research - Thomas Metzner, MS
Adjuvant Therapy - Sandy Srinivas, M.D.
29:57
Adjuvant Therapy - Sandy Srinivas, M.D.
Discussion Jordan Chavez
36:17
Discussion Jordan Chavez
Genomics of Kidney Cancer - Alexey Aleshin, M.D., MBA
26:42
Genomics of Kidney Cancer - Alexey Aleshin, M.D., MBA
Immunotherapy - Sumit Shah, M.D., M.P.H.
31:45
Immunotherapy - Sumit Shah, M.D., M.P.H.